the catheter, howevcr, it can be relocated at anv time by repeating the procedure described above.
The figure shows a side-opening catheter, but the results we obtained with a catheter having a single hole at the tip appear to be the same. 
Comment
We used this method on more than 50 patients and found the results indistinguishable from those of the fluid bridge (pressure) test. The test is reproducible, though the distance from the bladder neck at which the result is positive may vary slightly with the strength of the cough.
The importance of the fluid bridge test has already been established and it appears to be a more sensitive indicator of bladder neck incompetence than other urodynamic tests, with the possible exception of pressure-cine-cystography. Five mothers aged 27-36 years were given fluoride by mouth on the third postpartum day. A dose of 1-5 mg was given as an aqueous solution of sodium fluoride in the morning after fasting for 10 hours. Blood and breast milk were sampled simultaneously in a non-glass system before and 30, 60, 90, and 120 minutes after the dose. Fluoride concentration in plasma was measured with a fluoride-sensitive electrode,1 and in milk was determined using a modified microdiffusion technique.2 Recovery experiments showed no evidence that fluoride binds to the constituents of breast milk. Hence the figures given for breast milk represent exclusively free fluoride.
The plasma fluoride concentration in all subjects rapidly increased after fluoride intake (figure). The highest plasma concentrations appeared 30 minutes after dosing, when they varied between 3-6 and 4-5 jsmol/l (70 and 86 ng/ml). This rapid absorption was in line with our results from oral single-dose studies in man.3 There was no corresponding increase in the fluoride concentrations in the breast milk, the values varying between 0-1 and 0-4 tsmol/l (2 and 8 ng/ml). 
These findings show that plasma fluoride is poorly transferred to breast milk and infants thus receive almost no fluoride during breast feeding. This is in contrast to another halogen, bromide, which reportedly accumulates in breast milk.4
In this study plasma and milk were sampled for a period of two hours after a single dose had been taken by the mother. The possibility of delayed transfer, not detected during the period of observation, was ruled out by other results from our laboratory, which showed that fluoride concentrations in breast milk remain steady, even when fluoride is given repeatedly and despite considerable variations in the maternal plasma fluoride concentrations.
The reason for the poor transfer of fluoride into the cells of the breast is obscure. Such a phenomenon has not been observed in other mammalian glands-for example, the salivary glands. The concentration in saliva follows that in plasma, and the,ratio between salivary and plasma fluoride is around 0-65.3 Fluoride is excluded from certain cultured cells,5 but whether the same mechanisms are concerned in the mammary gland remains to be clarified.
Infants fed on milk substitutes receive higher fluoride doses, especially in areas where the drinking water is rich in fluoride. Thus in an area where the fluoride concentration is one part per million the daily fluoride dose in the newborn infant will be about 800-1000 fig when a milk substitute is used, whereas the fluoride dose for breast-fed children in the same area will not exceed 10 lAg/day. The existence of a physiological plasma-milk barrier against fluoride suggests that the newborn is actively protected from this halogen. Hence the recommendation made in several countries to give breastfed infants fluoride supplementation should be reconsidered. After a report was published in 1977 from the Royal College of General Practitioners' Oral Contraceptive Study,' which suggested a possible association between use of oral contraceptives and haemorrhagic stroke, a case-control study of fatal subarachnoid haemorrhage was carried out by Inman.2 This showed a small, but not statistically significant, increased risk of subarachnoid haemorrhage in association with oral-contraceptive use in the absence of hypertension, though it was considered that use of oral contraceptives might be related indirectly by raising blood pressure. We report the results of a further study of this problem.
Methods and results
The methodology is discussed in detail elsewhere. (results of lumbar puncture or the presence of subhyaloid haemorrhage). The table shows that there were no significant differences between cases and controls in their current or past use of oral contraceptives. Similar results were obtained when cases with only clinical evidence of subarachnoid haemorrhage were excluded and when separate age groups were analysed.
The known risk factors for subarachnoid haemorrhage were more prevalent in cases than controls: hypertension (33 cases (20 %,,), 9 controls (3 ,)), a history of pre-eclamptic toxaemia (11 (7 %O) and 6 (2°,')), renal disease (5 (3 %) and 2 (1 ')), and a previous subarachnoid haemorrhage (9 (5%) and none). Oral-contraceptive use in women with and without risk factors is shown in the table. The 33 cases diagnosed as hypertensive showed a higher rate of past use (55 %) and a lower rate of current use (9 0%) when compared with non-hypertensive cases. Twelve of the 18 past users had been diagnosed as hypertensive when using oral contraceptives and had stopped using the pill for this reason. Data on smoking were available for only 75 (45 %°) cases and 95 (28 %) controls, but among these women there were more smokers in cases (61 %) than controls (32 (%o). Although fewer cases who were using oral contraceptives were taking a preparation containing less than 50 jig oestrogen (9 out of 27 compared with 36 out of 65) the difference was not significant.
Comment
This study confirms the importance of known risk factors for subarachnoid haemorrhage. There have been five previous studies2 4 5 examining the role of oral contraceptives in the aetiology of subarachnoid haemorrhage. Three showed a statistically significant increase in risk associated with oral-contraceptive use,2 4 one a small but not significant increase in risk,2 and one no association.5 The present study shows a small but not significant increase in risk. As Inman has suggested2 oral contraceptives might act indirectly by raising blood pressure: 15 of the 33 patients with hypertension were first found to have raised levels of blood pressure while taking the pill. This effect was not great enough, however, to result in a significant difference in oral-contraceptive use. These findings taken with those of earlier studies suggest that both the relative and absolute risks of subarachnoid haemorrhage associated with use of oral contraceptives are small and are probably associated with the hypertensive effect of the pill. 
